The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study

BACKGROUND: In March 2020, Veterans Health Administration (VHA) enacted policies to expand treatment for Veterans with opioid use disorder (OUD) during COVID-19. In this study, we evaluate whether COVID-19 and subsequent OUD treatment policies impacted receipt of therapy/counseling and medication fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Livingston, Nicholas A., Davenport, Michael, Head, Michael, Henke, Rachel, LeBeau, Lavonia Smith, Gibson, Teresa B., Banducci, Anne N., Sarpong, Alexis, Jayanthi, Saketh, Roth, Clara, Camacho-Cook, Jessica, Meng, Frank, Hyde, Justeen, Mulvaney-Day, Norah, White, Mackenzie, Chen, Daniel C., Stein, Michael D., Weisberg, Risa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624112/
https://www.ncbi.nlm.nih.gov/pubmed/36368167
http://dx.doi.org/10.1016/j.drugalcdep.2022.109678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624112/
https://www.ncbi.nlm.nih.gov/pubmed/36368167
http://dx.doi.org/10.1016/j.drugalcdep.2022.109678

Ejemplares similares